List view / Grid view
15 April 2019 | By European Pharmaceutical Review
Following reports of immune-mediated conditions and problems with the heart and blood vessels (including fatal cases), the EMA (European Medicines Agency) has started a review of the multiple sclerosis medicine, Lemtrada.
4 April 2019 | By European Pharmaceutical Review
The prescription drug pregabalin is now being treated as a class C drug...
4 April 2019 | By European Pharmaceutical Review
The US Food and Drug Administration has posted warning letters to four companies who produce homeopathic drug products for significant violations of current good manufacturing practice (cGMP) regulations...
26 March 2019 | By European Pharmaceutical Review
The MHRA has recalled three batches of Losartan tablets due to contamination with the nitrosamine N-nitroso-N-methylamino butyric acid...
18 March 2019 | By European Pharmaceutical Review
Birth control pill recalled because they may contain defective blisters with incorrect tablet arrangements and potential empty blister pocket...
4 March 2019 | By Nikki Withers (European Pharmaceutical Review)
FDA is 'deeply concerned' about a third type of nitrosamine impurity detected in angiotensin II receptor blocker (ARB) medicines...
21 February 2019 | By Hyglos-bioMerieux
This article covers the analytical criteria that apply to Bacterial Endotoxin Testing (BET) using Limulus Amebocyte Lysate (LAL) or recombinant Horseshoe crab Factor C (rFC) for the bioactivity determination of endotoxin in aqueous solutions, such as pharmaceuticals and medical device extracts. It explains the importance of these criteria for accurate…
19 February 2019 | By European Pharmaceutical Review
Researchers have found that fluconazole used to treat yeast infections in pregnant women could cause a higher risk of miscarriage...
7 February 2019 | By European Pharmaceutical Review
A combination therapy using the blood thinner cilostazol, along with either aspirin or clopidogrel, was shown to decrease the risk of stroke recurrence...
6 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
The antidepressant drug, trazodone, taken for anxiety and depression, has been found not to be linked to a reduced risk of dementia...
25 January 2019 | By European Pharmaceutical Review
Researchers have suggested that benzodiazepines should be the first course of treatment for those with cardiovascular disease and anxiety...
23 January 2019 | By Iqra Farooq (European Pharmaceutical Review)
A study has found that long term aspirin use increases patients' risk of major bleeding events by 43 percent, with 1 in 200 having a major bleed...
17 January 2019 | By European Pharmaceutical Review
Combining benzodiazepines, opioids and Z-drugs could prove to cause serious adverse outcomes including breathing problems and fatalities...
21 December 2018 | By Arianna Pinto, Lisa Pincus, Luis Jimenez, Sibora Peca, Stephanie Perez
The contamination of pharmaceuticals by microorganisms represents a major threat to public health, not just in the USA and Europe, but all around the world. Pathogenic microorganisms cause morbidity and in some cases mortality when present in products.1,2 Spoilage due to microbial breakdown of formulations can affect potency and shelf…
18 December 2018 | By Merck
Used to detect a broad range of pyrogens in parenteral products including pharmaceuticals, biopharmaceuticals and medical devices, the Monocyte Activation Test (MAT) gives an in vitro alternative to conventional animal testing in accordance with regulatory guidelines.
Follow: